RB1 and prostate carcinoma: A number of studies have demonstrated that, in prostate carcinoma cells, silibinin causes hypophosphorylation of retinoblastoma (Rb) protein, an increase in Rb-E2 factor (E2F) complexes, and substantial decreases in some of the E2F family members [42,43].